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http://dx.doi.org/10.1016/j.stemcr.2017.06.001SUMMARYHuman embryonic stem cells (hESCs) hold great promise for the treatment ofmany incurable diseases. Sirtuin1 (SIRT1), a class III histone
deacetylase, is abundantly expressed in hESCs and is known to regulate early differentiation and telomere elongation. Here, we show that
downregulation of SIRT1 promotes cell death in hESCs, but not in differentiated cells, and the SIRT1-inhibition-mediated cell death is
preceded by increased DNA damage. This increased DNA damage is at least partially due to decreased levels of DNA repair enzymes
such asMSH2,MSH6, and APEX1. Furthermore, SIRT1 inhibition causes p53 activation, which eventually leads to DNA damage-induced
apoptosis of hESCs. This study provides valuable insights into themechanism of SIRT1-mediated hESC survival and should contribute to
the development of safe and effective cell therapies.INTRODUCTION
Human pluripotent stem cells (hPSCs), such as human em-
bryonic stem cells (hESCs) and induced pluripotent stem
cells (iPSCs), are characterized by their capacity to prolifer-
ate indefinitely and to differentiate into most cell types in
the human body. Because of these unique properties,
hPSCs hold great promise for the treatment of many incur-
able diseases through cell replacement therapy (Hwang
et al., 2010; Yoo et al., 2013).
Despite more than a decade of intensive research, under-
standing of the physiology and functional regulation of
hPSCs, especially hESCs, remains far from complete. The
rapid proliferation of hESCs, which is caused primarily by
a shortened G1 phase and a rapid G1/S transition, increases
the risk of replication errors and enhances the levels of reac-
tive oxygen species within these cells (Becker et al., 2006).
A variety of internal factors and external environmental
stimuli, such as genotoxic chemicals and physical stimuli
(e.g., ionizing radiation, UV light), are potential causes of
different forms of DNA damage, such as single-strand
breaks, abasic sites, DNA adducts, and double-strand breaks
(DSBs) (Houtgraaf et al., 2006). Such DNA damage in turn
induces various intracellular responses, such as cell cycle
changes, the activation of DNA repair machineries, and
apoptosis.
Sirtuin1 (SIRT1) is a nicotinamide adenine dinucleotide
(NAD+)-dependent class III histone deacetylase that is
known to regulate stress responses, genomic stability, and
cell survival (Chung et al., 2006; Terada et al., 2002; Ying
et al., 2002). Previous work has shown that the DNA dam-
age repair system does not function properly in SIRT1Stem Cell
This is an open access article under the Cmutant mice (Wang et al., 2008). In addition, several
studies have implicated SIRT1 in DNA repair and cell sur-
vival in cancer cells (Kalle et al., 2010; Kojima et al.,
2008; Lin and Fang, 2013), which is consistent with the
abnormal SIRT1 protein levels in many cancer cells (Elan-
govan et al., 2011; Huffman et al., 2007; Kuzmichev
et al., 2005). To date, the role of SIRT1 in hESCs has re-
mained poorly understood. Recent studies have suggested
a link between Sirt1 and the differentiation of mouse
ESCs (mESCs), hematopoietic stem cells, and mesen-
chymal stem cells (Calvanese et al., 2010; Lee et al., 2012;
Ou et al., 2011; Simic et al., 2013; Tang et al., 2014). In
particular, Ou et al. (2011) have reported that Sirt1
knockout mice display defects in hematopoietic differenti-
ation and the formation of a primitive vasculature. Sirt1
has also been shown to enhance the reprogramming of
mouse fibroblasts (Lee et al., 2012), facilitate telomere elon-
gation inmouse iPSCs (De Bonis et al., 2014), andmaintain
the pluripotency of hESCs (De Bonis et al., 2014; Zhang
et al., 2014). In addition, SIRT1 has been shown to induce
autophagy in response to oxidative stress in both mESCs
and hESCs (Ou et al., 2014). To date, most studies regarding
the functions of Sirt1 in pluripotent stem cells have been
performed usingmESCs, and understanding of SIRT1 func-
tions in hESCs remains far from complete. In particular, the
roles of SIRT1 in hESC genome stability and survival have
yet to be investigated in detail.
In this study, we sought to examine the role of SIRT1 in
hESC survival. Using proteomic analysis, we showed that
SIRT1 in hESCs critically modulates the levels of two
DNA mismatch repair enzymes, MSH2 and MSH3, and a
DNA base excision repair enzyme, APEX1, and providedReports j Vol. 9 j 629–641 j August 8, 2017 j ª 2017 The Author(s). 629
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. SIRT1 Levels Are High in hESCs
and Are Greatly Decreased in Differenti-
ated Cells
(A) SIRT1 expression levels in hESCs and
differentiated cells (EBs and NPs) were
measured by qRT-PCR. Decreased SIRT1
expression was observed in EBs and NPs
compared with hESCs. Data are shown as
means ± SEM (n = 6 independent experi-
ments; *p < 0.05).
(B) SIRT1 expression levels in hESCs, EBs,
and NPs were compared by western blotting.
(C) Immunocytochemistry shows the co-
localization of SSEA4 (green) and SIRT1
(red) immunoreactivity sites. The white
dashed lines demarcate differentiated cells.
(D) Flow cytometric analysis for SSEA-4
(phycoerythrin, PE) and SIRT1 (fluorescein
isothiocyanate, FITC) surface antigen
expression was performed on hESCs (left
panel) or NPs (right panel). Numbers shown
in the individual quadrants indicate the
percentage of cells of each type.evidence that SIRT1 is critically implicated in DNA repair
processes that in turn affect the genome stability and sur-
vival of hESCs.RESULTS
SIRT1 Is Abundantly Expressed in hESCs
Previous reports have shown that Sirt1 protein regulates
the pluripotency and differentiation of mESCs (Ou et al.,
2011; Zhang et al., 2014). We first compared the level of
SIRT1 among hESCs and their differentiated derivatives,
such as embryoid bodies (EBs) and neural precursors
(NPs). qRT-PCR showed that SIRT1 mRNA levels were at
least 4-fold higher in hESCs than in EBs and NPs (Fig-
ure 1A). Western blotting also showed that SIRT1 protein
levels were significantly higher in hESCs than in EBs and
NPs (Figure 1B). Furthermore, immunocytochemistry
clearly showed that SIRT1 was strongly expressed in undif-
ferentiated (SSEA4+) hESCs (Figure 1C, top two panels),
whereas its expression was drastically decreased in a large
population of differentiated (SSEA4) cells (Figure 1C, top
panels, the areas surrounded by white dotted lines). A
merged image clearly showed that most sites of SIRT1
and SSEA4 immunoreactivity were co-localized (Figure 1C,
bottom right panel, inside the white dotted circle).
Flow-cytometric analysis showed that most hESCs
(91.5%) displayed immunoreactivity toward both SSEA4
and SIRT1, thus demonstrating co-expression of SSEA4
and SIRT1in hESCs at a cellular level (Figure 1D, left panel).
However, the expression of both markers was simulta-630 Stem Cell Reports j Vol. 9 j 629–641 j August 8, 2017neously downregulated (i.e., SSEA4+ SIRT1+ = 3.91%,
SSEA4 SIRT1 = 75.4%) in NPs that were differentiated
from hESCs (Figure 1D, right panel).
Together, our results demonstrated a high SIRT1 level in
hESCs but not in differentiated cells (i.e., EB and NPs). This
dramatic change in SIRT1 level suggested that Sirt1 is criti-
cally involved in the physiology of hESCs.
SIRT1 Inhibition Induced Apoptosis in hESCs
SIRT1 has been reported to decrease apoptotic cell death in
cancer cells (Kalle et al., 2010; Kojima et al., 2008). In this
study, we hypothesized that one of the functions of
SIRT1 in hESCsmight be to protect the cells from apoptotic
cell death. To elucidate the potential involvement of SIRT1
in hESC survival, we examined how knocking down the
level or inhibiting the function of SIRT1 affected hESC sur-
vival/death. First, western blotting confirmed that hDFs,
which were used as a negative control (i.e., differentiated
cells), did not express SIRT1, whereas hESCs displayed sig-
nificant SIRT1 expression (Figure 2A).
When hESCs were treated for 12 hr with Tenovin-6, a
SIRT1/2 inhibitor, hESCs in compact colonies were severely
damaged (Figure 2B, top right panel), whereas hDFs re-
mained intact under the same conditions (Figure 2B, bot-
tom right panel). Next, we observed that a 12-hr treatment
with Tenovin-6 induced a significant increase in cleaved
caspase-3 (C-CAS3), an apoptotic marker, in hESCs, but
not in hDFs (Figure 2C). Flow-cytometric analysis using an-
nexin V and propidium iodide (PI) to evaluate apoptosis
showed a significant increase in apoptotic cells after
Tenovin-6 (5 mM, 12 hr) treatment in hESCs (i.e., from
Figure 2. Tenovin-6 Treatment Leads to Cell Death in hESCs but Not in Differentiated Cells
(A) A representative immunoblot showing the difference in SIRT1 expression level between undifferentiated cells (hESCs) and fully
differentiated cells (hDFs).
(B) Typical phase-contrast images of hESCs and hDFs were taken after Tenovin-6 (5 mM) treatment for 12 hr.
(C) Immunocytochemistry showed that cleaved caspase-3 (C-CAS 3) immunoreactivity dramatically increased after Tenovin-6 treatment
(2 mM, 12 hr). The areas surrounded by white dashed lines demarcate the areas composed of undifferentiated hESCs.
(D) Flow cytometric analysis of hESCs was performed after Tenovin-6 treatment (5 mM, 12 hr). y Axis, propidium iodide (PI); x axis,
annexin V (FITC-labeled).
(E) Percentages of apoptotic cells obtained from flow-cytometric analysis of hESCs treated with Tenovin-6 (5 mM, 12 hr). Data are shown as
means ± SEM (n = 6 independent experiments; *p < 0.05).
(F) Flow-cytometric analysis of hDFs was performed after Tenovin-6 treatment (5 mM, 12 hr). y Axis, PI; x axis, annexin V (FITC-labeled).
(G) Flow-cytometric analysis of apoptotic cells using PI and an annexin V antibody was performed at 48 hr after transfection with
siRNA-aSIRT1.
(H) The three histograms derived from each independent flow cytometric analysis are shown. In the experiments, the number of apoptotic
cells was counted at 48 hr after transfection of hESCs with either siRNA-aSIRT1 or siRNA-aSIRT2. An FITC-conjugated annexin V antibody
was used for the analysis (n = 3 independent experiments).4.86% to 22.54%) (Figures 2D and 2E), but not in hDFs
(Figure 2F). Repeated experiments consistently showed
that the percentage of apoptotic cells was significantly
increased after Tenovin-6 treatment in a time-dependent
manner, reaching nearly 40% at 16 hr post treatment (Fig-
ures S1A and S1B). Moreover, treatment of hESCs and hDFs
with other SIRT1 inhibitors, such as Sirtinol (50 mM), Sale-rmide (50 mM), and EX527 (5 mM), also induced cell death
of only hESCswithout affecting hDFs (Figure S1C). Because
EX527 is a selective SIRT1 inhibitor that does not block
other SIRT family proteins, it is evident that SIRT1 inhibi-
tion induces hESC death (Figure S1C, top rightmost panel).
To further confirm the involvement of SIRT1 in the regu-
lation of hESC death, we specifically knocked down SIRT1Stem Cell Reports j Vol. 9 j 629–641 j August 8, 2017 631
Figure 3. Proteomic Analysis Showed that
SIRT1 Inhibition Significantly Decreased
DNA Repair Proteins in hESCs
(A) Volcano plot of differentially expressed
proteins (DEPs) between control and SIRT1-
inhibited groups. Fold change (in log2) is
plotted against the Edge R-generated p value
(log base 2). Differential expression analysis
identified 219 DEPs between the control and
SIRT1-inhibited groups: a total of 140 and 79
proteins were downregulated and upregulated
by SIRT1 inhibition, respectively. The 140
downregulated proteins were divided into 46
stringently regulated proteins (red-brown
squares, log2 < 1, p < 1.03 100.2) and 94
moderately regulated proteins (pear-green
triangles, 1 < log2 < 0, p < 1.0 3 100.2).
Likewise, the 79 upregulated proteins were
divided into 23 stringently regulated proteins
(red-brown squares, log2 > 1, p < 1.03 10
0.2)
and 56 moderately regulated proteins (pear-
green triangles, 0 < log2 < 1, p < 1.03 10
0.2).
(B) The protein-protein interaction biochemical network was generated using the STRING database (Search Tool for the Retrieval of
Interacting proteins) (http://string-db.org/) and provided information on proteins that either directly or indirectly interact with SIRT1.
(C) Western blotting of SIRT1, MSH2, MSH6, and APEX1 was performed at 12 hr post transfection.
(D) Representative western blotting of hESCs treated with resveratrol (10 mM) for 24 hr was performed to examine the levels of SIRT1 and
DNA repair proteins (MSH2 and MSH6).
(E) Western blotting of MSH2, MSH6, and APEX1 was performed after hESCs were treated with a combination of a SIRT1 inhibitor and/or a
proteasome inhibitor (DMSO only, Tenovin-6 only, Tenovin-6 + MG132, and MG132 only).using an SIRT1-specific small interfering RNA (siRNA-
aSIRT1) and examined the degree of cell death by flow-cy-
tometric analysis using an annexin V antibody and PI (Fig-
ure 2G). The knockdown specificity of siRNA-aSIRT1 used
in this experiment was confirmed because it decreased
only the SIRT1mRNA level (Figure S2A). After transfection
of hESCs with siRNA-aSIRT1, the SIRT1 mRNA level was
decreased in a reverse time-dependent manner, probably
because of the degradation of transfected siRNA-aSirt1
over time (Figure S2B). At 48 hr after siRNA-aSIRT1 trans-
fection, we still observed a significant number of apoptotic
cells (2.7%, siRNA-Scrambled versus 28.9%, siRNA-aSIRT1)
(Figure 2G).
When we examined the contribution of SIRT2 to hESC
survival/death by using an siRNA specific for SIRT2 (Fig-
ure S2C), no significant induction of cell death was de-
tected (Figure 2H), thus suggesting that SIRT2 plays only
a marginal role in the regulation of hESC survival. This
result also indicated that a large portion of cell death
induced by Tenovin-6 treatment (i.e., inhibition of SIRT1
and 2) is caused by blocking SIRT1 (Figure 2H).
Together, our results demonstrated that either blocking
the function or decreasing the level of SIRT1 robustly
enhanced hESC death, thus indicating that SIRT1 is critical
for the survival of hESCs.632 Stem Cell Reports j Vol. 9 j 629–641 j August 8, 2017Proteomic Analysis Showed that SIRT1 Inhibition
Significantly Decreased DNA Repair Proteins in hESCs
To gain mechanistic insight into the early events occurring
after SIRT1 inhibition, we treated hESCswith Tenovin-6 for
2 hr and performed proteomic analysis. A total of 1,401
different proteins were identified using isobaric tags for
relative and absolute quantification (iTRAQ)-based proteo-
mic analysis. Of these, 140 and 79 proteins were downregu-
lated and upregulated, respectively, in hESCs treated with
Tenovin-6 compared with cells treated with DMSO (con-
trol) (Figure 3A and Tables S1–S4). The 140 downregulated
proteins were divided into 46 stringently regulated pro-
teins (red-brown squares) and 94moderately regulated pro-
teins (pear-green triangles) (Figure 3A, left half; Tables S1
and S2). Likewise, the 79 upregulated proteins were divided
into 23 stringently regulated proteins (red-brown squares)
and 56moderately regulated proteins (pear-green triangles)
(Figure 3A, right half; Tables S3 and S4).
Next, we performed KEGG pathway enrichment analysis
and found that the enriched categories included pathways
involved in DNA repair. Notably, MSH2 and MSH6, which
are involved in repairing DNA base mismatches, and
APEX1, which has been implicated in DNA excision repair,
were found in the stringently downregulated group (Fig-
ure 3A). The protein-protein interaction biochemical
network generated using the STRING database (Search Tool
for the Retrieval of Interacting proteins database) (http://
string-db.org/) provided information on proteins that
either directly or indirectly interact with SIRT1. Analysis
of this protein network showed that SIRT1 was closely
linked to several important DNA repair proteins, including
MSH2, MSH6, and APEX1 (Figure 3B).
Together, these results suggest the intriguing possibility
that SIRT1 interacts with several DNA repair proteins and
that these interactions may be responsible for SIRT1-medi-
ated hESC survival.
Proteomic Analysis Data Were Validated by Western
Blotting
We first examined whether our proteomic data were reli-
able. To this end, we chose several up- and downregulated
proteins and validated the expression of these proteins
by using western blotting. All four upregulated proteins
examined, PDI, T-PLASTIN, VDAC1, and VIMENTIN,
were detected at a higher level in Tenovin-6-treated hESCs
than in control (DMSO-treated) hESCs (Figure S3A). In
addition, the levels of four downregulated proteins,
MTHF1, MYOSIN, FILAMIN1, and EZRIN, were lower in
Tenovin-6-treated hESCs than in control hESCs (Fig-
ure S3B). These western blot results confirmed the validity
of our proteomic data.
Next, we examined the levels of the three DNA repair
proteins, MSH2, MSH6, and APEX1, which were shown
to be downregulated by Tenovin-6 treatment in our prote-
omic analysis. For western blotting, we transfected hESCs
with siRNA-Scrambled and siRNA-aSIRT1 and collected
samples at 12 hr post transfection. As expected, the protein
levels of SIRT1,MSH2,MSH6, andAPEX1were decreased in
cells transfected with siRNA-aSIRT1 (Figure 3C).
To further confirm the role of SIRT1 in regulating the pro-
tein expression of MSH2, MSH6, and APEX1, we elevated
the SIRT1 protein level by treating hESCs with resveratrol,
a SIRT1 activator. Our western blotting results showed that
increasing SIRT1 by resveratrol treatment upregulatedDNA
repair proteins such as MSH2 and MSH6 (Figure 3D).
Intriguingly, the MSH2, MSH6, and APEX1 mRNA levels
did not decrease after Sirt1 knockdown (data not shown).
This observation contrasted with the decreased protein
levels of these DNA repair genes after SIRT1 inhibition,
thus suggesting the involvement of post-transcriptional
regulation.
To understand the mechanisms underlying the decrease
in DNA repair proteins without the decrease in their
respective mRNAs after SIRT1 inhibition, we tested
whether SIRT1 inhibition induced the proteasomal degra-
dation of these DNA repair enzymes. To this end,we treated
cells with Tenovin-6 along with a proteasome inhibitor,
MG132. The significant decrease in DNA repair proteins af-ter Tenovin-6 treatment did not occur when MG132 was
also added, thus indicating that proteasomal degradation
is involved in the SIRT1-mediated regulation of DNA repair
enzyme levels (Figure 3E). This result suggested that the
decrease in the three DNA repair proteins, MSH2, MSH6,
and APEX1, after SIRT1 inhibition was at least partly due
to enhanced proteasomal degradation.
Together, our data demonstrated that a high level of
SIRT1 protein in hESCs increases several DNA repair pro-
teins and the proteasomal degradation pathway is at least
partly involved in the SIRT1-mediated regulation of the
DNA repair proteins.
SIRT1 Inhibition Increased DNA Damage in hESCs
Because we found a link between the levels of SIRT1
and DNA repair proteins, we examined whether blocking
SIRT1 activity eventually leads to increased DNA damage.
First, we performed apurinic/apyrimidinic (AP)-site stain-
ing of hESCs after Tenovin-6 treatment (5 mM, 12 hr): AP
sites are themost common formof single-strandDNAdam-
age (Demple andHarrison, 1994). Tenovin-6-treated hESCs
displayed a large number of AP-site-positive cells, whereas
control (DMSO-treated) cells showed no prominent AP
sites (Figure 4A, upper two panels and graph). As a positive
control, hESCs were treated with epigallocatechin gallate
(EGCG), which reacts with the culture medium and gener-
ates hydrogen peroxide (H2O2) and further causes DNA
damage (Figure 4A, lower two panels). These results sug-
gested that SIRT1 inhibition causes a concomitant increase
in single-strand DNA breaks in hESCs.
Next, we sought to examine whether SIRT1 inhibition in
hESCs might promote more severe DNA damage such as
DNA DSBs, which are known to cause apoptotic cell death
(Roos and Kaina, 2006). Phosphorylated H2AX (g-H2AX) is
a good indicator of DSBs, because DSBs are typically fol-
lowed by histone H2AX phosphorylation (Kinner et al.,
2008). Treatment of hESCs with Tenovin-6 for 12 hr
increased the number of g-H2AX+ cells in a dose-depen-
dent manner (Figures 4B and 4C). Nuclear staining with
DAPI showed that the compact colony morphology was
lost at high concentrations of Tenovin-6 (i.e., 5 mM and
10 mM) (Figure 4B, lower panels). By contrast, hDFs did
not display anymorphological changes at the high concen-
trations of Tenovin-6 used in this study (i.e., 5 mM) (Fig-
ure S4A), in agreement with the results in Figures 2B and
2F. In addition, few g-H2AX+ cells were detected in hDFs
after Tenovin-6 (5 mM) treatment (Figure S4A).
To examine the correlation between DNA damage and
cell death, we examined the number of g-H2AX+ and
Dead Green+ (a marker for cell death) cells at both 2 hr
and 6 hr. At 2 hr post treatment, some g-H2AX+ cells
were observed, whereas few Dead Green+ cells appeared
(Figures S4B [upper panels] and 4D). A significant numberStem Cell Reports j Vol. 9 j 629–641 j August 8, 2017 633
Figure 4. Tenovin-6 Treatment Induces DNA Damage in hESCs
(A) Immunofluorescence analysis of AP (apurinic/apyrimidinic) sites in hESCs treated with Tenovin-6 (5 mM, 12 hr) and EGCG (5 mM, 12 hr)
as a positive control. The data were quantified and are presented in a graph (lower right panel). Data are shown as means ± SEM (n = 3
independent experiments; **p < 0.01).
(B) Immunofluorescence analysis showed that the number of hESCs containing DSBs (g-H2AX+) also increased in a dose-dependent manner
after Tenovin-6 treatment.
(C) The number of g-H2AX+ cells per 70 mm2 DAPI+ area is presented as a bar graph. Data represent means ± SEM (n = 3 independent
experiments; **p < 0.01).
(D) The numbers of Dead Green+ and g-H2AX+ cells were counted at 2 hr and 6 hr after Tenovin-6 (5 mM) treatment and plotted in the graph.
Data represent means ± SEM (n = 6 independent experiments; *p < 0.05, **p < 0.005).
(E) The percentages of the total g-H2AX+ cells that were Dead Green+ were measured and presented as a bar graph. Data are shown as
means ± SEM (n = 6 independent experiments; *p < 0.01, **p < 0.001).of Dead Green+ cells and g-H2AX+ cells were detected at
6 hr, and g-H2AX+ cells outnumbered Dead Green+ cells
(Figures S4B [lower panels] and 4D). Intriguingly, a large
portion of g-H2AX+ cells were positive for Dead Green at
6 hr (>60%) (Figure 4E), and noDead Green+ g-H2AX cells
were detected (Figure S4B), thus indicating the close rela-
tionship between DSB DNA damage and cell death
after Tenovin-6 treatment. In addition, H2AX phosphory-
lation preceded cell death in hESCs (Figures 4D and S4B),
thus further suggesting that DNA DSBs were at least
partly responsible for cell death after SIRT1 inhibition.
These results confirmed that Tenovin-6 treatment resulted
in increased DNA damage (i.e., DSBs) and subsequent
apoptotic cell death.
Because Tenovin-6 inhibits the functions of both SIRT1
and SIRT2 (Lain et al., 2008), we examined the effect
of only SIRT1 by specifically knocking down SIRT1634 Stem Cell Reports j Vol. 9 j 629–641 j August 8, 2017mRNA by using siRNA-aSIRT1. As expected, DNA DSBs
were drastically increased at 24 and 48 hr after siRNA-
aSIRT1 transfection in hESCs, but not in hDFs (Figures
5A and 5B).
In addition, enhancement of SIRT1 expression by resver-
atrol treatment decreased the oxidative stress (H2O2)-
induced increase in DNA DSBs, thus indicating a clear
role of SIRT1 in the decrease in DNA damage (Figure 5C).
Together, our results demonstrated that SIRT1 plays a
critical role in preventing DNA damage in hESCs, which
in turn protects hESCs from death.
SIRT1 Knockdown Marginally Induced hESC
Differentiation
To determine whether SIRT1 is involved in hESC differ-
entiation, as previously shown (De Bonis et al., 2014;
Zhang et al., 2014), we analyzed hESCs at 72 hr after
Figure 5. SIRT1 Plays a Major Role in Genome Stability and Is Marginally Involved in hESC Differentiation
(A) Immunofluorescence images showing the numbers of hESCs and hDFs with DSB DNA damage (g-H2AX+) at 24 hr and 48 hr after
transfection with siRNAs (siRNA-Scrambled and siRNA-aSIRT1).
(B) Percentages of total cells (DAPI+ cells) that were g-H2AX+. Data are shown as means ± SEM (n = 6 independent experiments; *p < 0.01,
**p < 0.001).
(C) Histogram showing intracellular g-H2AX+ levels of hESCs treated with 2.5 mM H2O2 in the absence or presence of resveratrol pre-
treatment (10 mM, 24 hr).
(D) The level of SSEA-4 (phycoerythrin, PE), an undifferentiated cell marker, was examined using flow-cytometric analysis at 72 hr after
transfection with siRNAs (siRNA-Scrambled and siRNA-aSIRT1).
(E) Real-time qPCR analysis of the mRNA levels of SIRT1, NESTIN, SOX17, and BRACHYURY genes at 72 hr after transfection with siRNAs
(siRNA-Scrambled [siCon] and siRNA-aSIRT1). Data are shown as means ± SEM (n = 3 independent experiments; **p < 0.005).transfection with siRNA-aSIRT1. Our flow cytometric
analysis displayed a slight decrease in the SSEA4+ (undif-
ferentiated) cell population after SIRT1 knockdown (Fig-
ure 5D), thus indicating a slight induction of differen-
tiation by SIRT1 knockdown. Furthermore, we detected
an increase in NESTIN, a neuroectoderm marker, whereas
mesoderm and endoderm lineage markers were not
changed (Figure 5E).
Our results together showed some evidence of hESC neu-
ral differentiation, although the most dramatic effects de-
tected after SIRT1 inhibition or knockdown were increased
DNA damage and subsequent cell death.Tenovin-6-Mediated p53 Acetylation Was Not
Required for the EarlyDecrease inDNARepair Proteins
We already showed that SIRT1 inhibition induced
apoptotic cell death of hESCs (Figure 2). Because DNAdam-
age activates p53 through acetylation (Sakaguchi et al.,
1998), which in turn results in apoptosis (Sykes et al.,
2006; Tang et al., 2006), we examined whether Tenovin-6
treatmentmight promote p53 acetylation with subsequent
induction of apoptosis in hESCs. Our western blotting
analysis showed that the levels of acetylated (activated)
p53 and cleaved caspase-3were significantly increased after
Tenovin-6 treatment (5 mM, 12 hr) in hESCs, but not inStem Cell Reports j Vol. 9 j 629–641 j August 8, 2017 635
Figure 6. Tenovin-6-Mediated p53 Acet-
ylation Was Not Required for the Early
Decrease in DNA Repair Proteins
(A) Western blotting for p53 (a known
target of SIRT1), acetylated-p53 (an active
form of p53), and cleaved caspase-3 (an
apoptotic marker) was performed in cells
with or without Tenovin-6 treatment (5 mM,
12 hr) (left panel). The morphologies of the
cells used for western blotting are shown on
the right.
(B) Expression levels of PUMA and BAX, two
pro-apoptotic genes, were examined by
real-time qPCR in cells with or without
Tenovin-6 treatment (5 mM, 12 hr). Data
represent means ± SEM (n = 3 independent
experiments; *p < 0.05, **p < 0.005).
(C) Western blotting for SIRT1, acetylated
p53 (acetyl-p53), MSH2, MSH6, APEX1, and
actin (a loading control) was performed at
2 hr after treatment with Tenovin-6 (5 mM).hDFs (Figure 6A). This result was consistent with our previ-
ous immunostaining and flow cytometry data showing a
significant increase in hESC death at 12 hr after Tenovin-6
treatment (Figure 2). Our qRT-PCR results showed that
SIRT1 inhibition increased the expression of PUMA and
BAX, pro-apoptotic p53 target genes, in hESCs (Figure 6B),
thus indicating a connection between SIRT1 inhibition
and p53-mediated apoptosis of hESCs.
We next examined whether the decrease in the DNA
repair proteins after Tenovin-6 treatment occurred through
p53 acetylation. To detect which event occurs first, we
performed western blotting at an early time point after
Tenovin-6 treatment. In this experiment we examined
only an acetylated form of p53, because Lain et al. (2008)
have shown that Tenovin-6 does not change the level of
total p53 (as seen also in our data, Figure 6A) and does
not activate p53 by phosphorylation. Strikingly, treatment
of hESCs with Tenovin-6 for 2 hr resulted in a decrease in
MSH2, MSH6, and APEX1 proteins, whereas no acetylated
form of p53 was apparent at this time point (Figure 6C).
This result suggested that the decrease in the DNA repair
proteins does not require p53 activation, at least during
the early stage.
Together, our results indicated no evidence of a func-
tional connection between acetylated p53 and the decrease
in DNA repair proteins. It is plausible that the DNA dam-
age-induced apoptosis after SIRT1 inhibition in hESCs oc-636 Stem Cell Reports j Vol. 9 j 629–641 j August 8, 2017curs through a p53-independent mechanism, at least dur-
ing early events (i.e., decrease in DNA repair proteins).
This study provides valuable insights into the mechanism
underlying the SIRT1-mediated survival of hESCs.DISCUSSION
hESCs have unlimited proliferation potential and typically
have a shorter cell cycle (approximately 15.8 hr) thanmost
somatic cells (24–32 hr), owing to a shortened G1 phase
(approximately 2.5–3 hr) and a faster G1/S transition
(Becker et al., 2006). hESCs retain pluripotency because
they are derived from the inner cell mass of blastocysts,
which can generate any type of cell in the human body
after full development.
It may be reasonable to speculate that cells from early
developmental stages (i.e., cells that constitute the inner
cell mass and hESCs) retain efficient DNA repair systems,
because the introduction of DNA defects during early
developmental stages would be disastrous and lead to in-
herited mutations in differentiated cells. In support of
this idea, mESCs have been reported to show more effi-
cient DNA repair activity than fibroblasts after oxidative
stress- and ionizing radiation-induced DNA damage
(Saretzki et al., 2004). Furthermore, hESCs are prone to
undergo apoptosis at lower doses of IR exposure than
somatic cells, thus decreasing the chances of propagating
abnormal cells with DNA defects. These observations sug-
gest that hESCs have a fail-safe strategy to decrease cells
with defective genetic information by boosting DNA
repair systems and/or inducing apoptosis of defective
cells (Filion et al., 2009; Sokolov et al., 2012; Wilson
et al., 2010). These fail-safe strategies are of great impor-
tance in allowing hESCs to avoid any disastrous out-
comes derived from the propagation of cells into
different cell types with DNA abnormalities. Cells
constantly undergo DNA damage in the form of nucleo-
tide changes, abasic sites, and single-strand breaks. If
these defects are not efficiently corrected, they eventually
form lethal DSBs during DNA replication, when replica-
tive DNA polymerases encounter single-strand breaks.
DSBs are extremely detrimental to cells and often cause
chromosomal translocations, which are associated with
tumor formation and even cell death (Kaina, 2003;
Khanna and Jackson, 2001; Rich et al., 2000; Richardson
and Jasin, 2000). In response to DNA damage, hESCs ar-
rest at the G2/M checkpoint, activate DNA repair systems
such as BER, MMR, and DSB repair, and finally induce
apoptosis, depending on the severity of damage or the
success of the DNA repair processes (Liu et al., 2014;
Momcilovic et al., 2010).
In our study we found that SIRT1 was required for
hESC survival, because SIRT1 inhibition robustly induced
apoptotic cell death. Strikingly, we found that inhibiting
SIRT1 activity dramatically decreased the level of three
DNA repair proteins, MSH2, MSH6, and APEX1. Both
MSH2 and MSH6 are principal components of MutS (e.g.,
themismatch repair complex), andMutS dysfunction leads
to single-strand DNA damage (Westmoreland and Resnick,
2013). APEX1 is a major component of BER, and APEX1
malfunction also leads to single-strand DNA damage
(Hable et al., 2012). The single-strand DNA damage gener-
ated by SIRT1 inhibition became DSBs and eventually
caused apoptosis. In accordance with this finding, resvera-
trol treatment increased the expression of SIRT1 and,
hence, DNA repair proteins (Figure 3D), thereby decreasing
DSBs in response to genotoxic stress (Figure 5C). Evidently,
this observationwas in agreementwith findings from a pre-
vious report indicating that SIRT1 overexpression leads to
increased survival after oxidative stress (Oberdoerffer
et al., 2008). Consequently, our findings indicated that
SIRT1 is a critical regulator in the orchestration of multiple
DNA repair systems and is important for maintaining
genomic fidelity and integrity in hESCs.
One important issue to consider is whether p53 plays a
critical role in the associations among SIRT1 inhibition,
DNA damage induction, and DNA damage-mediated
apoptosis. On the basis of previous reports showing that
SIRT1 inhibition activates p53 through acetylation, it isconceivable that Tenovin-6 treatment enhances p53
acetylation in hESCs, which in turn leads to (1) a rapid
decrease in DNA damage repair proteins, (2) a subsequent
increase in DNA damage, and (3) DNA DSB-mediated
apoptosis. To resolve this issue, we examined the levels
of acetylated p53 and the three DNA repair proteins in
hESCs at an early time point (i.e., 2 hr) after Tenovin-6
treatment. Strikingly, the levels of all three DNA repair
proteins analyzed, MSH2, MSH6, and APEX1, were rapidly
decreased in the absence of p53 acetylation, thus suggest-
ing that acetylated p53 may not be responsible for the
rapid decrease in the DNA repair proteins (Figure 6C).
Intriguingly, we observed DSBs as early as 2 hr after
Tenovin-6 treatment (Figure S4B), thus also indicating
that DNA DSBs begin forming rapidly in the absence of
acetylated p53. Therefore, it is plausible that activation
of p53 by SIRT1 inhibition may not be involved in early
events (i.e., decrease in DNA repair proteins and induction
of DNA damage) but may be involved in the late stage (i.e.,
DSB-mediated apoptosis) of SIRT1/DNA damage-mediated
apoptosis (Figure 7).
At this stage, we donot fully understand how SIRT1mod-
ulates the level of DNA repair proteins. However, our results
demonstrated a connection between SIRT1 and the protea-
some pathway. Although beyond the scope of this study,
it would be interesting to unveil the detailed mechanism
explaining the link between SIRT1 and the proteasome-
mediated decrease in DNA repair proteins.
In summary, our study showed that SIRT1 is indispens-
able for hESC survival and that the modulation of the
levels of multiple DNA repair proteins is at least partially
responsible for the SIRT1-mediated prevention of cell
death (Figure 7). Given the ever-increasing importance
of hESCs as a cell source for replacement therapy,
this study offers valuable insight into the growth and
maintenance of DNA damage-free hESCs for clinical
applications.EXPERIMENTAL PROCEDURES
Culture of hESCs
The human ESC line H9 (WiCell) was cultured in hESC medium
containing DMEM-F12 supplemented with 20% Knockout-Serum
Replacement medium (Invitrogen), 13 non-essential amino acids
(Invitrogen), 0.1 mM b-mercaptoethanol (Sigma), and 4 ng/mL
basic fibroblast growth factor (bFGF) (Invitrogen) on a layer of
mitotically arrested STO cells (ATCC). hESC colonies were trans-
ferred onto fresh feeder cells every 7 days by either a mechanical
method or enzymatic passaging using collagenase type IV (Sigma).
For feeder-free culture, hESCs were cultured on Matrigel-coated
dishes in TeSR-E8 medium (STEMCELL Technologies). All the
hESC experiments were approved by the Institutional Ethical
Committee, Yonsei University College of Medicine (4-2015-1097).Stem Cell Reports j Vol. 9 j 629–641 j August 8, 2017 637
Figure 7. The Mechanism Underlying the Role of SIRT1 in hESC Survival
A high activity/level of SIRT1 in hESCs maintains sufficient levels of certain DNA repair enzymes. For example, we detected a significant
decrease in MSH2 and MSH6 as well as APEX1 after inhibition or knockdown of SIRT1. The efficient repair of genetic aberrations by these
DNA repair proteins prevents small mutations from progressing into hazardous DSBs, which eventually lead to cellular apoptosis. In the
absence of SIRT1 activity in hESCs, the level of several DNA repair enzymes is rapidly decreased by the proteasome and/or another unknown
pathway. The early rapid decrease in the DNA repair proteins does not appear to be mediated by acetylated p53. The lack of sufficient DNA
repair allows DSB DNA damage to dramatically increase, and this is followed by increased cell death. Acetylation of p53 and concomitant
BAX and PUMA overexpression have been implicated in the DNA damage-mediated apoptosis.Differentiation of hESCs In Vitro
hESC clumps were transferred to uncoated 35-mm bacterial dishes
(SPL Life Science) to be cultured as EBs in suspension culture, then
cultured onMatrigel-coated dishes in differentiationmedium. The
differentiation medium contained the same components as the
hESC medium, except that bFGF was omitted and 2% fetal bovine
serum was added (Invitrogen).
Transfection of Small Interfering RNAs
The siRNA sequences used in this study are as follows: siRNA-
aSIRT1 (forward: 50-GCA CAG AUC CUC GAA CAA UUC UU-30,
reverse: 50-GAA UUG UUC GAG GAU CUG UGC UU-30); siRNA-
aSIRT2 (forward: 50-GAA GAC AUU GCU UAU UGG AUU-30,
reverse: 50-UCC AAU AAG CAA UGU CUU CUU-30); and siRNA-
Scrambled (forward: 50-CCU CGU GCC GUU CCA UCA GGU
AGU U-30, reverse: 50-CUA CCU GAU GGA ACG GCA CGA GGT
T-30). Double-stranded siRNAs were synthesized by Genolution.
hESCs were treated with 10 mM ROCK inhibitor Y27632 (EMD
Millipore) for 1 hr before harvesting. The cells were dissociated
for 4 min using TrypLE Select (Invitrogen) and neutralized by
TeSR-E8 cell culture medium. The cells were centrifuged at 100 3
g for 3 min, washed with 13 PBS, and resuspended in R buffer
from theNeon Transfection system (Invitrogen). The reaction con-
tained 100 nM siRNA, and transfections were performed using the
Neon Transfection system at 900 V, 20 ms, and 1 pulse. The cells638 Stem Cell Reports j Vol. 9 j 629–641 j August 8, 2017were then immediately plated onto Matrigel-coated plates with
Y27632, followed by a medium change the next day.
Apoptosis Analysis
The apoptosis of hESCs was detected using a fluorescein isothio-
cyanate (FITC) Annexin V Apoptosis Detection Kit (BD Biosci-
ences). Cells were harvested and resuspended in binding buffer
at a concentration of 1 3 106 cells/mL. A total of 100 mL of the
solution was transferred to a 5-mL culture tube and treated
with 5 mL each of Annexin V-FITC and PI. The cell suspension
was incubated for 15 min at room temperature in the dark
and then analyzed by flow cytometry using a FACS LSRII (BD
Biosciences).
Western Blotting
Cells treated with various concentrations of Tenovin-6 were lysed
with RIPA buffer (Sigma) containing 13 protease inhibitor cocktail
(Roche Applied Science). The extracts (20 mg of total protein) were
separated on polyacrylamide-SDS gels and transferred to polyviny-
lidene fluoride membranes (Amersham). The membranes were
blocked with a solution containing 2% BSA/13 PBS and incubated
overnightwith a primary antibody at 4C. Subsequently, themem-
branes were incubated with a horseradish peroxidase-conjugated
secondary antibody (1:100) (Invitrogen). The reactive proteins
were visualized using an ECL substrate solution (Pierce) according
to the manufacturer’s instructions. Western blotting was per-
formed using antibodies (Table S6).
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde and permeabilized with
0.1% Triton X-100. The samples then were incubated with block-
ing buffer (2% BSA in 13 PBS). The cells were incubated overnight
with primary antibodies diluted in blocking buffer at 4C. Primary
antibodies (Table S6) to the following proteins were used: SSEA4
(Santa Cruz Biotechnology), cleaved caspase-3 (Cell Signaling
Technology), gH2AX (Invitrogen), and SIRT1 (Cell Signaling).
The samples were washedwith 13 PBS and incubated with fluores-
cently labeled secondary antibodies for 30 min at room tempera-
ture. The secondary antibodies used were Alexa Fluor 488- or Alexa
Fluor 594-labeled donkey immunoglobulin G (IgG)/goat IgG
(1:1,000; Invitrogen). A cover glass was mounted onto the slides
using Vectashield Hardset mounting medium (Vector Labora-
tories) containing DAPI (Invitrogen). Images were obtained on
a DP71 fluorescence microscope (Olympus) and an LSM700
confocal microscope (Carl Zeiss). The Image-iT Dead Green
viability stain (Invitrogen) was used to stain dead cells by incuba-
tion of the test cells with Dead Green (1:1,000) complete medium.
RNA Preparation and Real-Time qRT-PCR
Total mRNA was extracted using an Easy-Spin Total RNA Purifica-
tion Kit (iNtRON Biotechnology) and was used for first-strand
cDNA synthesis using a PrimeScript RT Reagent Kit (Takara Bio)
according to the manufacturer’s instructions. Real-time qRT-PCR
was performed using SYBR PremixExTaq (Takara Bio). Reactions
were performed on a CFX96 Real-Time System (Bio-Rad), and
the results were evaluated with CFX real-time detection system
software. Quantification was performed by determining the
threshold cycle value (CT), and target genes were normalized to
GAPDH (glyceraldehyde-3-phosphate dehydrogenase). Relative
target gene expression was quantified using the comparative CT
method. All PCRs were performed in triplicate. Primer sequences
are shown in Table S5.
Proteomic Analysis and the Protein-Protein
Interaction Network
A proteomic tandem mass spectrometry approach was applied
to reveal how proteins were differentially regulated by SIRT1 inhi-
bition in hESCs. To this end, hESCswere treatedwith Tenovin-6 for
2 hr and the differentially regulated proteins were analyzed with
respect to control (DMSO-treated)hESCs. iTRAQanalysis identified
a total of 219 differentially regulated proteins (>4-fold), of which
46 (stringent) and 94 (moderate) proteins were downregulated
and 23 (stringent) and 56 (moderate) proteins were upregulated.
To display the SIRT1-dependent protein regulation in hESCs,
we used the STRING database (http:/string-db.org) and KEGG
pathway enrichment analyses.
Apurinic/Apyrimidinic Site Analysis
A DNA damage-AP site-Assay kit (Cell-Based) (Abcam) was used for
the determination of abasic sites in genomicDNA, according to the
manufacturer’s instructions. In brief, hESCs were treated with
vehicle (control), 100 mM EGCG (positive control), or 5 mM Teno-vin-6 for 12 hr. The cells were then stained for AP sites with a DNA
damage-AP site-Assay kit. AP sites were labeled with avidin-FITC
and directly counted under an Olympus IX 71 microscope.
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